Q1 2025 Innovate Corp Earnings Call Transcript
Key Points
- Innovate Corp (VATE) reported consolidated revenues of $274.2 million and adjusted EBITDA of $7.2 million for the first quarter of 2025.
- DBM Global achieved revenues of $264.9 million with a gross margin improvement of 110 basis points year-over-year.
- MediBeacon received FDA approval for its transdermal GFR system, marking a significant milestone in their Life Sciences segment.
- R2 tripled its year-over-year revenue to $3.1 million, driven by increased demand in North America.
- Spectrum signed a contract with Marathon Ventures to distribute two new over-the-air networks, reflecting growth in the broadcasting and streaming industries.
- Consolidated total revenue decreased by 13% compared to the prior year period, primarily due to declines in the Infrastructure segment.
- Net loss attributable to common stockholders was $24.8 million, an increase from the previous year's net loss of $17.7 million.
- Adjusted EBITDA decreased from $12.8 million in the prior year period to $7.2 million, driven by declines in the Life Sciences and Infrastructure segments.
- Infrastructure segment revenue decreased by 14% due to the timing and size of projects at Banker Steel and the industrial maintenance and repair business.
- The company had $33.3 million of cash and cash equivalents at the end of the first quarter, down from $48.8 million at the end of 2024.
Good afternoon, and welcome to Innovate's first quarter 2025 earnings conference call. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference call over to Anthony Rozmus with Investor Relations. Please go ahead.
Good afternoon. Thank you for being with us to review Innovate's first quarter 2025 earnings results. We are joined today by Paul Voigt, Innovate's Interim CEO; and Mike Sena, Innovate's CFO. We have posted our earnings release and our slide presentation on our website at innovatecorp.com. We will begin our call with prepared remarks to be followed by a Q&A session.
This call is also being simulcast and will be archived on our website. During this call, management may make certain statements and assumptions, which are not historical facts, will be forward-looking and are being made pursuant to the Safe Harbor provisions and Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risks, assumptions and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
